Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Phibro Animal Health Corporation (PAHC)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
19.95+0.15 (+0.76%)
At close: 04:00PM EST
19.95 0.00 (0.00%)
After hours: 04:01PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
MACD

MACD

Previous Close19.80
Open19.77
Bid18.00 x 1400
Ask22.50 x 800
Day's Range19.50 - 20.27
52 Week Range18.63 - 31.00
Volume62,917
Avg. Volume74,451
Market Cap808.047M
Beta (5Y Monthly)0.58
PE Ratio (TTM)16.62
EPS (TTM)1.20
Earnings DateFeb 09, 2022
Forward Dividend & Yield0.48 (2.41%)
Ex-Dividend DateNov 23, 2021
1y Target Est21.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-16% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for PAHC

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Phibro Animal Health Corporatio
    PAHC: Lowering target price to $16.00PHIBRO ANIMAL HEALTH CORP-A has an Investment Rating of SELL; a target price of $16.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Medium.
    Rating
    Fair Value
    Economic Moat
    4 days agoArgus Research
View more
  • Business Wire

    Phibro Animal Health Corporation Welcomes FDA Hearing on Mecadox®

    TEANECK, N.J., January 12, 2022--Phibro Animal Health Corporation (NASDAQ:PAHC): Today, the Food and Drug Administration (FDA) provided notice in the Federal Register of its intention to hold a public hearing regarding Mecadox® (carbadox). Mecadox has been approved and sold in the United States for 50 years and is a widely used treatment for controlling bacterial diseases in swine, including Salmonella and swine dysentery, resulting in improved health and welfare for newly born and young pigs.

  • Business Wire

    Phibro Animal Health Corporation to Host Webcast and Conference Call on December 2021 Quarterly Financial Results

    TEANECK, N.J., January 06, 2022--Phibro Animal Health Corporation (Nasdaq:PAHC) expects to announce its second quarter financial results on Wednesday, February 9, 2022, after the market closes. Phibro management will host a conference call and webcast on Thursday, February 10, 2022, at 9:00 AM Eastern Time.

  • Zacks

    Here's Why You Should Retain Phibro (PAHC) Stock for Now

    Investors are optimistic about Phibro (PAHC), given robust performance by its nutritional specialties and vaccine product lines.

Advertisement
Advertisement